Related Experiment Video
Updated: Jul 4, 2026

Assessment of Viability of Human Fat Injection into Nude Mice with Micro-Computed Tomography
Published on: January 7, 2015
Recombinant Humanized Type III Collagen Enhances Fat Graft Retention by Promoting Angiogenesis and Adipocyte
Kaifang Hua1, Xinyu Zhang1, Jiyang Li1
1Department of Body Contouring & Fat Grafting Center, Plastic Surgery Hospital and Institute, Chinese Academy of Medical Sciences & Peking Union Medical College. Guo is a research scientist, Shanxi Jinbo Bio-Pharmaceutical Co., Ltd, Taiyuan, Shanxi, China.
Recombinant humanized type III collagen (rhCol III) significantly improves fat graft survival and retention. An optimal concentration of 4 mg/mL enhances adipocyte viability and vascularization for better autologous fat grafting outcomes.
Area of Science:
- Regenerative Medicine
- Biomaterials Science
- Tissue Engineering
Background:
- Autologous fat grafting (AFG) efficacy is often limited by inconsistent long-term fat graft retention.
- Type III collagen (Col III) is implicated in supporting crucial processes like angiogenesis, adipocyte survival, and immune modulation.
Purpose of the Study:
- To investigate the efficacy of recombinant humanized type III collagen (rhCol III) in enhancing fat graft survival.
- To determine if rhCol III improves fat graft retention in a concentration-dependent manner.
Main Methods:
- Human lipoaspirate was combined with varying concentrations of rhCol III (0, 2, 4, 8 mg/mL) or normal saline and grafted into mice.
- Post-grafting assessments included volume retention, histology, collagen deposition, adipocyte viability, and gene expression analysis (PPARG, CEBPA, VEGFA, FGF2).
- RNA sequencing and in vitro studies with human adipose-derived stem cells (ADSCs) were performed to elucidate rhCol III's molecular and cellular effects.
Main Results:
- rhCol III demonstrated reduced volume loss starting from week 2, with maximal retention observed at the 4 mg/mL concentration.
- Histological analysis revealed superior structural integrity of grafts treated with 4 mg/mL rhCol III.
- rhCol III significantly upregulated markers of adipogenesis (PPARG, CEBPA), vascularization (VEGFA, FGF2), and adipocyte/endothelial cell presence (Perilipin 1, CD31), with optimal effects at 4 mg/mL.
- In vitro, rhCol III enhanced ADSC proliferation, adhesion, migration, and adipogenesis, particularly at 4 mg/mL.
Conclusions:
- rhCol III effectively enhances fat graft retention by promoting angiogenesis, adipocyte viability, and beneficial immune remodeling.
- An optimal concentration of approximately 4 mg/mL rhCol III was identified for maximizing these effects.
- rhCol III presents significant potential as a biomaterial adjunct to improve the consistency and outcomes of autologous fat grafting procedures.
More Related Videos
08:43Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model
Published on: February 7, 2018
07:09Isolation of Murine Adipose Tissue-derived Microvascular Fragments as Vascularization Units for Tissue Engineering
Published on: April 30, 2017